Casera
Casera is a Seattle-based seed-stage startup that sells an AI-native patient progression platform to US acute care hospitals, using agentic AI to predict length-of-stay risk and autonomously resolve discharge barriers across payer, SNF, and transport workflows.
- Company typePrivate
- Founded2025
- HeadquartersSeattle, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Casera does
Casera is a Seattle-based, seed-stage healthcare technology company building an AI-native enterprise platform that manages patient progression across the full inpatient journey — from admission through discharge. The platform combines predictive analytics (LOS risk prediction and risk stratification on arrival) with agentic AI that autonomously coordinates downstream workflows including payer authorization, SNF placement, DME orchestration, and transport scheduling, plus auto-generated clinical round summaries and an executive dashboard tying throughput to DRG-level financial impact. Its primary customer is the acute care hospital and health system, with the platform addressing multiple stakeholders inside the hospital: case managers (core workflow), hospitalists and physicians (rounding intelligence), nurses (task prioritization), CNOs and quality leaders (throughput metrics), utilization review teams (payer authorization tracking), and CFOs (LOS-as-margin-lever quantification).
The company pursues a direct enterprise SaaS model targeting US hospital systems, with quote-based annual subscriptions scaled to hospital size or patient volume, a 'Request Demo' consultative sales motion, and a 90-day measurable ROI commitment as the primary value hook. Casera's go-to-market relies on its website as the lead capture surface, earned media coverage (GeekWire, 2025), and direct engagement with case management professionals through events such as the ACMA 2026 National Conference. The company emerged from Pioneer Square Labs (PSL) in 2025 and closed a $1,000,000 seed round led by PSL on December 9, 2025. As of the available data, Casera has 1-10 employees, no publicly disclosed customers or ARR, and is in early go-to-market execution.
Casera firmographics
Firmographics- Name
- Casera
- Legal name
- Casera
- Website
- https://casera.ai
- Company type
- Private
- Founded year
- 2025
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Casera is a Seattle-based seed-stage startup that sells an AI-native patient progression platform to US acute care hospitals, using agentic AI to predict length-of-stay risk and autonomously resolve discharge barriers across payer, SNF, and transport workflows.
- Ownership category
- akta.pro rank
Casera industry classification
Industry- Product category
- Healthcare Patient Progression Software
- NAICS
- Computer Systems Design and Related Services (54151)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Healthcare Provider ERP (Hospital Operations, Supply Chain, Finance) (HDAEAEAH)
- akta.pro secondary industry
- Order Sets, Care Plans & Clinical Pathways (CPOE-integrated) (HLACAGAC)
Keywords
Where Casera is headquartered
LocationHeadquarters
- HQ city
- Seattle
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Casera business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- SaaS Platform Subscription: Casera operates as a healthcare SaaS platform providing AI-native patient progression solutions to hospital systems. Given the enterprise sales motion, platform nature of the product, and emphasis on measurable ROI within 90 days, the revenue model is likely enterprise SaaS subscription with annual or multi-year contracts. Pricing would be based on hospital size or patient volume.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise hospital platform - custom pricing |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Casera product offering
Product offeringCore offering
Casera sells an AI-Native Enterprise Patient Progression Platform to hospitals and health systems that autonomously coordinates patient care from admission through discharge. The platform uses agentic AI to flag high LOS-risk patients on arrival, generate clinical round summaries, automate payer authorizations, coordinate SNF/DME/transport placements, and provide executive dashboards tracking avoidable days and ROI. It is delivered as enterprise SaaS with quote-based annual subscriptions and targets measurable ROI within 90 days.
Product overview
Casera offers a single unified AI-Native Enterprise Patient Progression Platform designed to reduce length of stay and eliminate avoidable days across the inpatient journey. The platform consists of the core patient progression intelligence system with integrated modules including LOS Risk Prediction, Care Team Coordination, Payer Automation, Post-Acute Coordination, Clinical Round Summaries, and an Executive Dashboard. From admission through discharge, the platform connects case managers, hospitalists, physicians, nurses, CNOs, quality leaders, utilization review teams, and CFOs with real-time intelligence and agentic AI capabilities to autonomously coordinate patient care and resolve barriers proactively.
Differentiator
Problem solved
Functional benefit
Products and services
- AI-Native Enterprise Patient Progression Platform Unified AI-native SaaS platform that connects every stakeholder across the inpatient journey from admission to discharge, using agentic AI to autonomously resolve discharge and patient progression barriers. It targets acute care hospitals and health systems seeking to reduce avoidable patient days and improve throughput, with modules for LOS risk prediction, care team coordination, payer automation, post-acute coordination, clinical round summaries, and executive dashboards.
Quantifiable outcome
- 15,000 avoidable days eliminated per year at a single hospital
- +3 more outcomes
Companies that use Casera
Customer profileSegments7 records
Ideal customer profiles1 record
Casera technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature8 records
Casera partnerships and signals
Strategic signalScale indicators3 records
Recent moves5 records
Expansion highlights5 records
Casera competitors and assessment
Company assessmentEmerging players
- Syllable: Syllable deploys AI agents for healthcare operations including patient access, scheduling, and care navigation. While focused on front-end patient interactions, it competes in the broader agentic AI for hospital workflows category alongside Casera.
- Olive AI: Olive AI built an AI workforce platform for healthcare revenue cycle and operational workflows before restructuring in 2024. It represents the broader category of AI-driven hospital operations automation where Casera competes.
Direct peers
- Notable: Notable provides intelligent automation for hospitals, using AI agents to handle administrative and clinical workflows like scheduling, registration, and care coordination. Casera's agentic AI positioning puts it in direct comparison as workflow automation expands beyond documentation.
- Care Logistics: Care Logistics offers hospital throughput and care coordination software focused on patient progression and length of stay reduction. Its core product area directly overlaps with Casera's patient progression platform for hospital systems.
- TeleTracking Technologies: TeleTracking is an established vendor for patient flow, bed management, and care progression in hospitals. Its operations command center and transfer center products overlap with Casera's patient progression and post-acute coordination capabilities.
- LeanTaaS: LeanTaaS provides AI-based capacity management and patient flow optimization for hospitals, including OR, inpatient, and infusion scheduling. It directly competes with Casera in using predictive and prescriptive AI to reduce LOS and improve hospital throughput.
- Qventus: Qventus is the closest direct competitor, offering AI-powered hospital operations automation that targets discharge planning, LOS reduction, and care coordination — the same problems Casera addresses. Both sell to hospital systems with a focus on turning analytics into operational action.
Broad incumbents
- Health Catalyst: Health Catalyst is an established healthcare data and analytics platform with operational improvement applications including throughput and care management. It competes as a broader incumbent offering analytics where Casera focuses on agentic action.
- Epic Systems: Epic is the dominant hospital EHR vendor with embedded care coordination, discharge planning, and patient flow functionality. As the incumbent platform in nearly all large US health systems, Epic is both a potential integration partner and the largest competitive threat to standalone patient progression platforms.
- WellSky: WellSky provides care coordination and care transition software spanning acute, post-acute, and home settings. Its post-acute and discharge planning capabilities overlap with Casera's SNF placement and post-acute coordination modules.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Casera financial estimates
Financial estimateRevenue estimate
Valuation estimate
Casera leadership team
Management profileNumber of profiles
Casera funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Casera M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Casera
What does Casera do?
Casera sells an AI-Native Enterprise Patient Progression Platform to hospitals and health systems that autonomously coordinates patient care from admission through discharge. The platform uses agentic AI to flag high LOS-risk patients on arrival, generate clinical round summaries, automate payer authorizations, coordinate SNF/DME/transport placements, and provide executive dashboards tracking avoidable days and ROI. It is delivered as enterprise SaaS with quote-based annual subscriptions and targets measurable ROI within 90 days.
Is Casera a public or private company?
Casera is a private company. It is classified as venture growth investor backed and is currently operating.
When was Casera founded?
Casera was founded in 2025. It employs 1 to 10 people.
Where is Casera based?
Casera is headquartered in Seattle, United States, in the North America region.
How does Casera make money?
One revenue line is on record: saaS Platform Subscription.
Who are Casera's main competitors?
Emerging players on record are Syllable and Olive AI. Direct peers are Notable, Care Logistics, TeleTracking Technologies, LeanTaaS and Qventus. Broad incumbents are Health Catalyst, Epic Systems and WellSky.
Does Casera have an API?
No public API is recorded for Casera.
What industry is Casera in?
Casera's product category is Healthcare Patient Progression Software. Its primary akta.pro industry code is HDAEAEAH, Healthcare Provider ERP (Hospital Operations, Supply Chain, Finance), with a secondary code of HLACAGAC, Order Sets, Care Plans & Clinical Pathways (CPOE-integrated). Its NAICS code is 54151 and its SIC code is 7372.